Posted on 10/19/20
Better Buy: Amgen vs. Bristol Myers Squibb
Amgen (NASDAQ:AMGN) and Bristol Myers Squibb (NYSE:BMY) share quite a few things in common. Both, of course, are big drugmakers with several successful products on the . . .
Posted on 10/19/20
Better Coronavirus Stock: Moderna vs. Sorrento Therapeutics
Explosive growth potential. That's the big draw for the stocks of small biotechs with COVID-19 development programs. One successful coronavirus vaccine or therapy could translate to . . .
Posted on 10/16/20
Is Alexion Pharmaceuticals a Buy?
Alexion Pharmaceuticals (NASDAQ:ALXN) develops therapies solely for rare diseases, so you probably haven't heard of most of the conditions that it makes drugs for. However, for . . .
Posted on 10/16/20
Praxis Precision Medicines Prices of Upsized IPO
CAMBRIDGE, Mass., Oct. 15, 2020 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies . . .
Posted on 10/15/20
Blue Cross Blue Shield Of Massachusetts Named A 'Best Company For Dads'
Blue Cross Blue Shield of Massachusetts has been named a "Best Company for Dads" by Working Mother in a recognition of the company's supportive policies. The . . .
Posted on 10/15/20
The Stepping Stones Group Acquires Ardor School Solutions
The Stepping Stones Group, a leading national provider of therapeutic, behavioral health, and autism services to children in educational and community settings
Posted on 10/15/20
Moderna Wins Permission to Submit Coronavirus Vaccine Candidate for Fast-Track Approval in Europe
Fresh off its announcement that it has submitted its coronavirus vaccine candidate for regulatory approval in Canada, Moderna (NASDAQ:MRNA) said Wednesday it is in a similar . . .
Posted on 10/14/20
Goldfinch Bio Honored by Goldman Sachs for Entrepreneurship
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Goldfinch Bio, a clinical stage biotechnology company focused on discovering and developing precision medicines for the treatment of kidney diseases, today announced that Goldman . . .
Posted on 10/14/20
Codiak Prices of IPO
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Codiak BioSciences, Inc., a clinical-stage company focused on pioneering the development of exosome-based therapeutics as a new class of medicines, today announced the pricing . . .
Posted on 10/14/20
Ocular Therapeutix Prices Public Offering of Common Stock
BEDFORD, Mass.--(BUSINESS WIRE)--Ocular Therapeutix, Inc. (Nasdaq: OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the . . .
Posted on 10/14/20
Dyno Therapeutics Enters Collaboration and License Agreement with Roche
Dyno Therapeutics, a biotech company applying artificial intelligence (AI) to gene therapy, today announced a collaboration and license agreement with Roche (SIX: RO, ROG; OTCQX: RHHBY) . . .
Posted on 10/14/20
Vericel Announces Preliminary Third Quarter 2020 Results
CAMBRIDGE, Mass., Oct. 14, 2020 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today . . .
Posted on 10/14/20
Nimbus Therapeutics Announces $60 Million Private Financing
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Nimbus Therapeutics, a biotechnology company designing breakthrough medicines through structure-based drug discovery and development, today announced the close of a $60 million private financing . . .
Posted on 10/14/20
Moderna's Coronavirus Vaccine Candidate Advances to Regulatory Review in Canada
Moderna's (NASDAQ:MRNA) coronavirus vaccine candidate is now under regulatory inspection north of our border. The company announced Tuesday morning that it has initiated a "rolling submission" . . .
Posted on 10/14/20
SpringWorks Therapeutics Closes Public Offering of Common Stock
STAMFORD, Conn., Oct. 13, 2020 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a clinical-stage biopharmaceutical company focused on developing life-changing medicines for patients with severe . . .
Posted on 10/13/20
Ocular Therapeutix Proposes Public Offering of Common Stock
BEDFORD, Mass.--(BUSINESS WIRE)--Ocular Therapeutix™, Inc. (Nasdaq: OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the . . .
Posted on 10/13/20
Codiak Prices IPO
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Codiak BioSciences, Inc., a clinical-stage company focused on pioneering the development of exosome-based therapeutics as a new class of medicines, today announced the pricing . . .
Posted on 10/13/20
Flexion Therapeutics Announces Preliminary Third-Quarter 2020
BURLINGTON, Mass., Oct. 13, 2020 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced preliminary ZILRETTA (triamcinolone acetonide extended-release injectable suspension) net sales of $23.6 million . . .
Posted on 10/13/20
3 Reasons Pfizer and BioNTech Will Have Coronavirus Vaccine Data Before Moderna
Pfizer (NYSE:PFE) and BioNTech (NASDAQ:BNTX) started the phase 3 clinical trial for their coronavirus vaccine BNT162b2 around the same time as Moderna (NASDAQ:MRNA) started its phase . . .
Posted on 10/12/20
LogicBio Therapeutics Closes Public Offering of Common Stock
LEXINGTON, Mass., (GLOBE NEWSWIRE) -- LogicBio Therapeutics, Inc. (Nasdaq:LOGC) (LogicBio), a company dedicated to extending the reach of genetic medicine with pioneering targeted delivery platforms, today . . .
Posted on 10/9/20
Bristol-Myers Squibb: FDA Inspection Secured
SummarySheep of Wall Street posted pictures of a supposed plant visit by FDA inspectors that's crucial to the Bristol-Myers/Celgene milestone.The photos have been met with some . . .
Posted on 10/9/20
Moderna Doesn't Plan to Enforce Coronavirus Vaccine Patents During Pandemic
Drugmakers live and die by the exclusivity provided by patents on their medications. Generic competition or even a branded competitor can substantially cut a company's market . . .
Posted on 10/8/20
scPharmaceuticals Provides Business Update
BURLINGTON, Mass.--(BUSINESS WIRE)--scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize therapies, advance patient care, and . . .
Posted on 10/8/20
Corbus Pharmaceuticals Announces Corporate Restructuring and Pipeline Portfolio Updates
Norwood, MA, Oct. 08, 2020 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP), a clinical-stage drug development company pioneering transformative medicines that target the endocannabinoid . . .
Posted on 10/8/20
DARPA Awards Moderna up to $56 Million
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Moderna, Inc., (Nasdaq: MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, . . .
Boston
